Article Information
History
- December 5, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Christos Korosa,b,
- Athina-Maria Simitsia,
- Anastasia Bougeaa,
- Nikolaos Papagiannakisa,
- Andreas Prentakisa,c,
- Dimitra Papadimitrioud,
- Ioanna Pachia,b,
- Efthalia Angelopouloua,
- Ion Beratisa,
- Efthymia Efthymiopouloua,
- Konstantinos Lourentzosb,
- Maria Bozib,
- Sokratis G. Papageorgioua,
- Xenia Geronicola Trapalic,
- Anastasios Bonakisb,
- Maria Stameloua,e,f and
- Leonidas Stefanisa,*
- a1st Department of Neurology, Eginition Hospital, National and Kapodistrian University of Athens, Athens, Greece
- b2nd Department of Neurology, Attikon Hospital, National and Kapodistrian University of Athens Athens, Greece
- cNuclear Medicine Unit, Attikon Hospital, Athens, Greece
- dNeurology Clinic, Henry Dunan Hospital, Athens, Greece
- eNeurology Clinic, Philipps University, Marburg, Germany
- fParkinson’s disease and Movement Disorders Dept., HYGEIA Hospital, Athens, Greece
- ↵*Corresponding author: Leonidas Stefanis, MD, PhD, 1st Department of Neurology, Eginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece and Center of Clinical Research, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, Greece, Address: Vasilisis Sofias 72 str, 11528 Athens, Telephone: 0030-2107289405, Fax: 0030-2107257621, Email: lstefanis{at}bioacademy.gr
Posted December 05, 2021.
Serum uric acid and total bilirubin as putative biomarkers of resistance in Prodromal Parkinson’s disease: Longitudinal data from the PPMI study
